These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 3549904)

  • 1. Expression of hemopoietic histocompatibility antigens on H-2-loss variants of F1 hybrid lymphoma cells: evidence consistent with trans gene regulation.
    Rembecki RM; Bennett M; Kumar V; Potter TA
    J Immunol; 1987 Apr; 138(8):2734-8. PubMed ID: 3549904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ability of H-2Dd molecule to affect natural resistance to hemopoietic allografts is an intrinsic property shared by Ddm1 but not Ld.
    Milisauskas VK; Nakamura I
    Eur J Immunol; 1994 Feb; 24(2):336-42. PubMed ID: 8299682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nature of hemopoietic histocompatibility determinants. Differential sensitivity of Hh-1b and H-2b determinants to tunicamycin.
    Milisauskas VK; Nakamura I
    J Immunol; 1988 Aug; 141(4):1246-51. PubMed ID: 2456347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allospecificities of B6D2F1 hybrid NK cell subsets defined by Ly-49A expression.
    Basiri H; Kiura K; DeNardin EG; Nakamura I
    J Immunol; 1995 Sep; 155(6):2822-32. PubMed ID: 7673698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rejection of bone marrow cell allografts by natural killer cell subsets: 5E6+ cell specificity for Hh-1 determinant 2 shared by H-2d and H-2f.
    Sentman CL; Kumar V; Bennett M
    Eur J Immunol; 1991 Nov; 21(11):2821-8. PubMed ID: 1718761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Class I H-2Db determinants are not involved in hybrid resistance to parental H-2b/Hh-1b bone marrow allograft.
    Milisauskas VK; Kaminsky SG; Nakamura I
    Eur J Immunol; 1987 Jul; 17(7):1043-9. PubMed ID: 2440692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific inhibition of hybrid resistance in F1 hybrid mice pretreated with parent-strain spleen cells. II. Evidence for an Hh-1 antigen-specific tolerization.
    Kosmatopoulos K; Scott-Algara D; Halle-Pannenko O
    J Immunol; 1988 Nov; 141(10):3285-92. PubMed ID: 2460528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow cell transplants involving intra-H-2 recombinant inbred mouse strains. Evidence that hemopoietic histocompatibility-1 (Hh-1) genes are distinct from H-2D or H-2L.
    Rembecki RM; Kumar V; David CS; Bennett M
    J Immunol; 1988 Oct; 141(7):2253-60. PubMed ID: 3049802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism of Hh-1, the mouse hemopoietic histocompatibility locus.
    Rembecki RM; Kumar V; David CS; Bennett M
    Immunogenetics; 1988; 28(3):158-70. PubMed ID: 2457549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemopoietic histocompatibility (Hh-1) regulatory and structural genes of the f haplotype map to H-2.
    Rembecki RM; Kumar V; David CS; Bennett M
    Transplantation; 1990 Mar; 49(3):633-8. PubMed ID: 2316021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leucyl-leucine methyl ester treatment of donor cells permits establishment of immunocompetent parent----F1 chimeras that are selectively tolerant of host alloantigens.
    Thiele DL; Calomeni JA; Lipsky PE
    J Immunol; 1987 Oct; 139(7):2137-42. PubMed ID: 3309052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of genetic resistance to marrow grafts in mice by interferon-alpha/beta.
    Afifi MS; Kumar V; Bennett M
    J Immunol; 1985 Jun; 134(6):3739-45. PubMed ID: 2985694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of the K and I regions of the H-2 complex in resistance to hemopoietic allografts.
    Drizlikh G; Schmidt-Sole J; Yankelevich B
    J Exp Med; 1984 Apr; 159(4):1070-82. PubMed ID: 6142918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abrogation of hybrid resistance to bone marrow engraftment by graft-vs-host-induced immune deficiency.
    Hakim FT; Shearer GM
    J Immunol; 1986 Nov; 137(10):3109-16. PubMed ID: 3095424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of newborn liver cells as a murine model for cord blood cell transplantation.
    Davenport C; Kumar V; Bennett M
    J Immunol; 1993 Aug; 151(3):1597-605. PubMed ID: 8101544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular loss variants of the murine major histocompatibility complex: nonexpression of H-2K antigens associated with marked reduction in H-2K mRNA as determined by oligonucleotide hybridization analysis.
    Zeff RA; Geier SS; Nathenson SG
    J Immunol; 1986 Aug; 137(4):1366-70. PubMed ID: 3734458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex and H-2 haplotype control the resistance of CBA-BALB hybrids to the induction of T cell lymphoma by Moloney leukemia virus.
    Storch TG; Chused TM
    J Immunol; 1984 Nov; 133(5):2797-800. PubMed ID: 6332861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AKR/J gene(s) unlinked to H-2 determines dominant inheritance of lymphocyte hyporesponsiveness to acetylcholine receptor.
    Gorzynski TJ; Lennon VA; Nathanson RM; David CS
    J Immunol; 1985 Apr; 134(4):2079-83. PubMed ID: 3919088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hybrid and allogeneic resistance to T cell grafts mediated by murine NK and CD8+ T cells.
    Davenport C; Haile A; Kumar V; Bennett M
    J Immunol; 1995 Mar; 154(6):2568-77. PubMed ID: 7876533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.